On the other hand, among patients with EOT-AFP <5.3 ng/mL, the percentage of patients with DCP levels above the upper limit at the onset of HCC was similar to that of patients with EOT-AFP ≥5.3 ng/mL (p = 0.477). This evidence concerns the gene AFP and hepatocellular carcinoma.